MM - 326
New IMS/IMWG Consensus Genomic Staging (CGS) Risk Criteria by Next-Generation Sequencing (NGS): Analysis of Daratumumab Benefit in Both High- and Standard-Risk Patients in the PERSEUS/EMN017 Study
Meletios A Dimopoulos
Poster Presenter: Meletios A Dimopoulos
